These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 25742875)

  • 41. Diagnosis of Menière's disease on MRI: feasibility at 1.5 Tesla.
    Kenis C; Crins T; Bernaerts A; Casselman J; Foer B
    Acta Radiol; 2022 Jun; 63(6):810-813. PubMed ID: 34000823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3D-real IR MRI of Meniere's disease with partial endolymphatic hydrops.
    Shi S; Zhou F; Wang W
    Am J Otolaryngol; 2019; 40(4):589-593. PubMed ID: 31113683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of three-dimensional magnetic resonance imaging of inner ear after intratympanic gadolinium injection, and clinical application of magnetic resonance imaging scoring system in patients with delayed endolymphatic hydrops.
    Gu X; Fang ZM; Liu Y; Lin SL; Han B; Zhang R; Chen X
    J Laryngol Otol; 2014 Jan; 128(1):53-9. PubMed ID: 24355544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between magnetic resonance imaging classification of endolymphatic hydrops and clinical manifestations and audiovestibular test results in patients with definite Ménière's disease.
    Jasińska A; Lachowska M; Wnuk E; Pierchała K; Rowiński O; Niemczyk K
    Auris Nasus Larynx; 2022 Feb; 49(1):34-45. PubMed ID: 33865653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visualization of endolymphatic hydrops after intratympanic injection of Gd-DTPA: comparison of 2D and 3D real inversion recovery imaging.
    Naganawa S; Sone M; Yamazaki M; Kawai H; Nakashima T
    Magn Reson Med Sci; 2011; 10(2):101-6. PubMed ID: 21720112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of endolymphatic hydrops by means of 3T magnetic resonance imaging after intratympanic administration of gadolinium.
    Tuñón Gómez M; Lobo Duro DR; Brea Álvarez B; García-Berrocal JR
    Radiologia; 2017; 59(2):159-165. PubMed ID: 28017456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging of Ménière's disease: early clinical experience in a UK centre.
    Pai I; Mendis S; Murdin L; Touska P; Connor S
    J Laryngol Otol; 2020 Apr; 134(4):302-310. PubMed ID: 32241307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere's disease: correlation of quantitative measures of endolymphatic hydrops with hearing.
    Sepahdari AR; Ishiyama G; Vorasubin N; Peng KA; Linetsky M; Ishiyama A
    Clin Imaging; 2015; 39(1):26-31. PubMed ID: 25457542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endolymphatic space imaging in patients with delayed endolymphatic hydrops.
    Kasai S; Teranishi M; Katayama N; Sugiura M; Nakata S; Sone M; Naganawa S; Nakashima T
    Acta Otolaryngol; 2009 Nov; 129(11):1169-74. PubMed ID: 19863306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-quality imaging of endolymphatic hydrops acquired in 7 minutes using sensitive hT
    Zou J; Chen L; Li H; Zhang G; Pyykkö I; Lu J
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2279-2290. PubMed ID: 34145490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MRI performed after intratympanic gadolinium administration in patients with Ménière's disease: correlation with symptoms and signs.
    Fiorino F; Pizzini FB; Beltramello A; Barbieri F
    Eur Arch Otorhinolaryngol; 2011 Feb; 268(2):181-7. PubMed ID: 20697903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visualization of endolymphatic hydrops after administration of a standard dose of an intravenous gadolinium-based contrast agent.
    Tanigawa T; Tamaki T; Yamamuro O; Tanaka H; Nonoyama H; Shiga A; Sato T; Ueda H
    Acta Otolaryngol; 2011 Jun; 131(6):596-601. PubMed ID: 21351819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of endolymphatic hydrops using 3-T MRI after intravenous gadolinium injection.
    Imai T; Uno A; Kitahara T; Okumura T; Horii A; Ohta Y; Sato T; Okazaki S; Kamakura T; Ozono Y; Watanabe Y; Hanada Y; Imai R; Ohata K; Inohara H
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4103-4111. PubMed ID: 28948373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endolymphatic space size in patients with Meniere's disease and healthy controls.
    Ito T; Kitahara T; Inui H; Miyasaka T; Kichikawa K; Ota I; Nario K; Matsumura Y; Yamanaka T
    Acta Otolaryngol; 2016 Sep; 136(9):879-82. PubMed ID: 27080254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endolymphatic space imaging in idiopathic sudden sensorineural hearing loss with vertigo.
    Chen X; Zhang XD; Gu X; Fang ZM; Zhang R
    Laryngoscope; 2012 Oct; 122(10):2265-8. PubMed ID: 22996668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections.
    Iida T; Teranishi M; Yoshida T; Otake H; Sone M; Kato M; Shimono M; Yamazaki M; Naganawa S; Nakashima T
    Acta Otolaryngol; 2013 May; 133(5):434-8. PubMed ID: 23294239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variability in the perilymphatic diffusion of gadolinium does not predict the outcome of intratympanic gentamicin in patients with Ménière's disease.
    Fiorino F; Pizzini FB; Barbieri F; Beltramello A
    Laryngoscope; 2012 Apr; 122(4):907-11. PubMed ID: 22374878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in endolymphatic hydrops in patients with Ménière's disease treated conservatively for more than 1 year.
    Suga K; Kato M; Yoshida T; Nishio N; Nakada T; Sugiura S; Otake H; Kato K; Teranishi M; Sone M; Naganawa S; Nakashima T
    Acta Otolaryngol; 2015 Sep; 135(9):866-70. PubMed ID: 26094970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness.
    Tagaya M; Teranishi M; Naganawa S; Iwata T; Yoshida T; Otake H; Nakata S; Sone M; Nakashima T
    Acta Otolaryngol; 2010 Jun; 130(6):665-9. PubMed ID: 19958242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.